Target intelligence / Profile preview

TBC1 domain family member 10C (TBC1D10C)

Target
TBC1D10C
Molecular classification
Enzyme (GTPase-activating protein, or GAP), Regulatory protein, Cytoskeletal linker
01

Overview

TBC1 domain family member 10C (TBC1D10C), also known as Carabin and EPI64C, is an enzyme belonging to the TBC domain family of GTPase-activating proteins (GAPs)[3][4][1]. It contains an N-terminal GAP domain that inhibits the small GTPases Ras and Rab35, and a C-terminal domain that binds and inhibits calcineurin, a key calcium/calmodulin-regulated phosphatase[1][3][4]. TBC1D10C acts as a negative regulator of Ras and calcineurin signaling pathways and thereby modulates lymphocyte activation, cell spreading, and phagocytosis, particularly in immune cells such as CD8 and CD4 T cells and macrophages[1][2][3]. It serves as a cytoskeletal functional linker and its deficiency has been linked to enhanced CD8 T-cell anti-tumor responses and altered autoimmune risk, suggesting disease relevance in cancer and immunological disorders[2][3]. While essential for negative regulation of immune activation, no drugs have yet been described that directly target TBC1D10C[3].

Other names
CarabinFLJ00332EPI64C
02

Mechanism of action

Not applicable (no drugs directly target this protein as of current knowledge); endogenous mechanism is inhibition of Ras and calcineurin signaling, and negative regulation of CD8 T cell activation via NF-κB pathway

03

Biological functions

Negative regulation of Ras signalingNegative regulation of calcineurin signalingRegulation of cytoskeleton-plasma membrane organizationModulation of immune cell activation (lymphocytes, macrophages)Regulation of phagocytosisInhibition of NF-κB signaling in CD8 T cells
04

Disease associations

CancerAutoimmunityImmune regulationCongenital disorder of glycosylation, type Ig
05

Safety considerations

No direct safety concerns, but broad inhibition could affect immune suppression and cytoskeletal dynamics, potentially influencing immune response or autoimmune risk

Beyond the preview

Go deeper on TBC1 domain family member 10C (TBC1D10C).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TBC1 domain family member 10C (TBC1D10C).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call